help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Weekers, F.
Right arrow Articles by Van den Berghe, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weekers, F.
Right arrow Articles by Van den Berghe, G.
Right arrowPubmed/NCBI databases
*Compound via MeSH
*Substance via MeSH
Hazardous Substances DB
*LIOTHYRONINE
Endocrinology Vol. 143, No. 3 764-774
Copyright © 2002 by The Endocrine Society


NEUROENDOCRINOLOGY

A Novel in Vivo Rabbit Model of Hypercatabolic Critical Illness Reveals a Biphasic Neuroendocrine Stress Response

Frank Weekers, Erik Van Herck, Willy Coopmans, Marina Michalaki, Cyril Y. Bowers, Johannes D. Veldhuis and Greet Van den Berghe

Department of Intensive Care Medicine (F.W., G.V.d.B., M.M.), Burn Unit and Center for Experimental Surgery & Anesthesiology and Laboratory for Experimental Medicine and Endocrinology (E.V.H., W.C.), Catholic University of Leuven, Leuven B-3000, Belgium; Department of Medicine (C.Y.B.), Division of Endocrinology, Tulane University Medical Center, New Orleans, Louisiana 70112-2699; and Department of Medicine (J.D.V.), Division of Endocrinology, University of Virginia Health Sciences Center, Charlottesville, Virginia 29908

Address all correspondence and requests for reprints to: Frank Weekers, M.D., Department of Intensive Care Medicine, University of Leuven, B-3000 Leuven, Belgium. E-mail: . Frank.Weekers{at}uz.kuleuven.ac.be

High doses of GH, used to induce anabolism in prolonged critically ill patients, unexpectedly increased mortality. To further explore underlying mechanisms, a valid animal model is needed. Such a model is presented in this study.

Seven days after arterial and venous cannulae placement, male New Zealand White rabbits were randomly allocated to a control or a critically ill group. To induce prolonged critical illness, a template controlled 15% deep dermal burn injury was imposed under combined general and regional (paravertebral) anesthesia. Subsequently, critically ill rabbits received supplemental analgesia and were parenterally fed with glucose, insulin, amino acids, and lipids. On d 1 and d 8 after randomization, acute and chronic spontaneous hormonal profiles of GH, TSH, and PRL secretion were obtained by sampling blood every 15 min for 7 h. Furthermore, GH, TSH, and PRL responses to an iv bolus of GH-releasing peptide 2 (GHRP-2) + TRH were documented on d 0, 1, and 8. Hemodynamic status and biochemical parameters were evaluated on d 0, 1, 3, 5, and 8, after which animals were killed and relative wet weight and water content of organs was determined.

Compared with controls, critically ill animals exhibited transient metabolic acidosis on d 1 and weight loss, organ wasting, systolic hypertension, and pronounced anemia on d 8. On d 1, pulsatile GH secretion doubled in the critically ill animals compared with controls, and decreased again on d 8 in the presence of low plasma IGF-I concentrations from d 1 to d 8. GH responses to GHRP-2 + TRH were elevated on d 1 and increased further on d 8 in the critically ill animals. Mean TSH concentrations were identical in both groups on d 1 and 8, in the face of dramatically suppressed plasma T4 and T3 concentrations in the critically ill animals. PRL secretion was impaired in the critically ill animals exclusively on d 8. TSH and PRL responses to GHRP-2 and TRH were increased only on d 1.

In conclusion, this rabbit model of acute and prolonged critical illness reveals several of the clinical, biochemical, and endocrine manifestations of the human counterpart.




This article has been cited by other articles:


Home page
EndocrinologyHome page
Y. Debaveye, B. Ellger, L. Mebis, T. J. Visser, V. M. Darras, and G. Van den Berghe
Effects of Substitution and High-Dose Thyroid Hormone Therapy on Deiodination, Sulfoconjugation, and Tissue Thyroid Hormone Levels in Prolonged Critically Ill Rabbits
Endocrinology, August 1, 2008; 149(8): 4218 - 4228.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
M. Depke, G. Fusch, G. Domanska, R. Geffers, U. Volker, C. Schuett, and C. Kiank
Hypermetabolic Syndrome as a Consequence of Repeated Psychological Stress in Mice
Endocrinology, June 1, 2008; 149(6): 2714 - 2723.
[Abstract] [Full Text] [PDF]


Home page
Nutr Clin PractHome page
B. Collier, L. A. Dossett, A. K. May, and J. J. Diaz
Glucose Control and the Inflammatory Response
Nutr Clin Pract, February 1, 2008; 23(1): 3 - 15.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
R. M. Luque, S. Park, and R. D. Kineman
Severity of the Catabolic Condition Differentially Modulates Hypothalamic Expression of Growth Hormone-Releasing Hormone in the Fasted Mouse: Potential Role of Neuropeptide Y and Corticotropin-Releasing Hormone
Endocrinology, January 1, 2007; 148(1): 300 - 309.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
Y. Debaveye, B. Ellger, L. Mebis, E. Van Herck, W. Coopmans, V. Darras, and G. Van den Berghe
Tissue Deiodinase Activity during Prolonged Critical Illness: Effects of Exogenous Thyrotropin-Releasing Hormone and Its Combination with Growth Hormone-Releasing Peptide-2
Endocrinology, December 1, 2005; 146(12): 5604 - 5611.
[Abstract] [Full Text] [PDF]


Home page
J. Leukoc. Biol.Home page
S. K. Andersen, J. Gjedsted, C. Christiansen, and E. Tonnesen
The roles of insulin and hyperglycemia in sepsis pathogenesis
J. Leukoc. Biol., March 1, 2004; 75(3): 413 - 421.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Weekers, M. Michalaki, W. Coopmans, E. Van Herck, J. D. Veldhuis, V. M. Darras, and G. Van den Berghe
Endocrine and Metabolic Effects of Growth Hormone (GH) Compared with GH-Releasing Peptide, Thyrotropin-Releasing Hormone, and Insulin Infusion in a Rabbit Model of Prolonged Critical Illness
Endocrinology, January 1, 2004; 145(1): 205 - 213.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
F. Weekers, A.-P. Giulietti, M. Michalaki, W. Coopmans, E. Van Herck, C. Mathieu, and G. Van den Berghe
Metabolic, Endocrine, and Immune Effects of Stress Hyperglycemia in a Rabbit Model of Prolonged Critical Illness
Endocrinology, December 1, 2003; 144(12): 5329 - 5338.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
G. Van den Berghe, D. Van Roosbroeck, P. Vanhove, P. J. Wouters, L. De Pourcq, and R. Bouillon
Bone Turnover in Prolonged Critical Illness: Effect of Vitamin D
J. Clin. Endocrinol. Metab., October 1, 2003; 88(10): 4623 - 4632.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 2002 by The Endocrine Society